array(40) {
  [0]=>
  string(4) "9512"
  ["article_id"]=>
  string(4) "9512"
  [1]=>
  string(63) "Soaring Medical Device Scrutiny: How is the Market Adapting?"
  ["article_title"]=>
  string(63) "Soaring Medical Device Scrutiny: How is the Market Adapting?"
  [2]=>
  string(150) "In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US "
  ["short_description"]=>
  string(150) "In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US "
  [3]=>
  string(514) "
In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US are adapting to a rise in regulatory controls. 
&#nl
The post Soaring Medical Device Scrutiny: How is the Market Adapting? appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(514) "
In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US are adapting to a rise in regulatory controls. 
&#nl
The post Soaring Medical Device Scrutiny: How is the Market Adapting? appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(104) "https://medtechintelligence.com/news_article/soaring-medical-device-scrutiny-how-is-the-market-adapting/"
  ["blog_url"]=>
  string(104) "https://medtechintelligence.com/news_article/soaring-medical-device-scrutiny-how-is-the-market-adapting/"
  [15]=>
  string(19) "2024-08-16 13:11:53"
  ["add_date"]=>
  string(19) "2024-08-16 13:11:53"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:26:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:26:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9445"
  ["article_id"]=>
  string(4) "9445"
  [1]=>
  string(49) "Corrections NZ invests $5M in EHR and more briefs"
  ["article_title"]=>
  string(49) "Corrections NZ invests $5M in EHR and more briefs"
  [2]=>
  string(89) "Also, Gold Coast Health is trying out an AI scribe to support clinical documentation.&#nl"
  ["short_description"]=>
  string(89) "Also, Gold Coast Health is trying out an AI scribe to support clinical documentation.&#nl"
  [3]=>
  string(89) "Also, Gold Coast Health is trying out an AI scribe to support clinical documentation.&#nl"
  ["description"]=>
  string(89) "Also, Gold Coast Health is trying out an AI scribe to support clinical documentation.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(87) "https://www.healthcareitnews.com/news/anz/corrections-nz-invests-5m-ehr-and-more-briefs"
  ["blog_url"]=>
  string(87) "https://www.healthcareitnews.com/news/anz/corrections-nz-invests-5m-ehr-and-more-briefs"
  [15]=>
  string(19) "2024-08-16 10:19:16"
  ["add_date"]=>
  string(19) "2024-08-16 10:19:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9335"
  ["article_id"]=>
  string(4) "9335"
  [1]=>
  string(75) "Novartis Loses First Round Battle Against Generic Entresto — For Now"
  ["article_title"]=>
  string(75) "Novartis Loses First Round Battle Against Generic Entresto — For Now"
  [2]=>
  string(158) "&#nl        Novartis’ 2022 complaint against several generic drugmakers for allegedly infringing on a patent for its blockbuster heart failure drug Ent"
  ["short_description"]=>
  string(158) "&#nl        Novartis’ 2022 complaint against several generic drugmakers for allegedly infringing on a patent for its blockbuster heart failure drug Ent"
  [3]=>
  string(310) "&#nl        Novartis’ 2022 complaint against several generic drugmakers for allegedly infringing on a patent for its blockbuster heart failure drug Entresto (sacubitril/valsartan) was denied on Tuesday, but the judge gave the company a stay in the order to allow it to appeal in federal court.&#nl      "
  ["description"]=>
  string(310) "&#nl        Novartis’ 2022 complaint against several generic drugmakers for allegedly infringing on a patent for its blockbuster heart failure drug Entresto (sacubitril/valsartan) was denied on Tuesday, but the judge gave the company a stay in the order to allow it to appeal in federal court.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(106) "https://www.fdanews.com/articles/214020-novartis-loses-first-round-battle-against-generic-entresto-for-now"
  ["blog_url"]=>
  string(106) "https://www.fdanews.com/articles/214020-novartis-loses-first-round-battle-against-generic-entresto-for-now"
  [15]=>
  string(19) "2024-08-16 01:00:14"
  ["add_date"]=>
  string(19) "2024-08-16 01:00:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9446"
  ["article_id"]=>
  string(4) "9446"
  [1]=>
  string(76) "AllianceChicago CIO discusses technology-enabled approaches to health equity"
  ["article_title"]=>
  string(76) "AllianceChicago CIO discusses technology-enabled approaches to health equity"
  [2]=>
  string(163) "Advancing "techquity" demands that providers be all in with collaboration, transparency and inclusivity, says Andrew Hamilton, RN – who offers insig"
  ["short_description"]=>
  string(163) "Advancing "techquity" demands that providers be all in with collaboration, transparency and inclusivity, says Andrew Hamilton, RN – who offers insig"
  [3]=>
  string(257) "Advancing "techquity" demands that providers be all in with collaboration, transparency and inclusivity, says Andrew Hamilton, RN – who offers insights about public health surveillance and the collection and use of social care needs data.&#nl"
  ["description"]=>
  string(257) "Advancing "techquity" demands that providers be all in with collaboration, transparency and inclusivity, says Andrew Hamilton, RN – who offers insights about public health surveillance and the collection and use of social care needs data.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(111) "https://www.healthcareitnews.com/news/alliancechicago-cio-discusses-technology-enabled-approaches-health-equity"
  ["blog_url"]=>
  string(111) "https://www.healthcareitnews.com/news/alliancechicago-cio-discusses-technology-enabled-approaches-health-equity"
  [15]=>
  string(19) "2024-08-16 00:18:03"
  ["add_date"]=>
  string(19) "2024-08-16 00:18:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9336"
  ["article_id"]=>
  string(4) "9336"
  [1]=>
  string(89) "Pharma Claims “Devastating” Consequences from Just-Released IRA Drug Pricing "
  ["article_title"]=>
  string(89) "Pharma Claims “Devastating” Consequences from Just-Released IRA Drug Pricing "
  [2]=>
  string(158) "&#nl        From a warning that the new pricing scheme doesn’t mean patients are protected from increased costs to another that the Inflation Reduction"
  ["short_description"]=>
  string(158) "&#nl        From a warning that the new pricing scheme doesn’t mean patients are protected from increased costs to another that the Inflation Reduction"
  [3]=>
  string(342) "&#nl        From a warning that the new pricing scheme doesn’t mean patients are protected from increased costs to another that the Inflation Reduction Act (IRA) pricing scheme will limit patients’ access to medicines now and in the future, big pharma has expressed its displeasure with the public unveiling of prices.&#nl      "
  ["description"]=>
  string(342) "&#nl        From a warning that the new pricing scheme doesn’t mean patients are protected from increased costs to another that the Inflation Reduction Act (IRA) pricing scheme will limit patients’ access to medicines now and in the future, big pharma has expressed its displeasure with the public unveiling of prices.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(114) "https://www.fdanews.com/articles/214022-pharma-claims-devastating-consequences-from-just-released-ira-drug-pricing"
  ["blog_url"]=>
  string(114) "https://www.fdanews.com/articles/214022-pharma-claims-devastating-consequences-from-just-released-ira-drug-pricing"
  [15]=>
  string(19) "2024-08-15 23:53:08"
  ["add_date"]=>
  string(19) "2024-08-15 23:53:08"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9337"
  ["article_id"]=>
  string(4) "9337"
  [1]=>
  string(50) "FDA Seeks Comments on Eight Drugs on Behalf of WHO"
  ["article_title"]=>
  string(50) "FDA Seeks Comments on Eight Drugs on Behalf of WHO"
  [2]=>
  string(153) "&#nl        The FDA is inviting comments, for consideration by WHO, concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact"
  ["short_description"]=>
  string(153) "&#nl        The FDA is inviting comments, for consideration by WHO, concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact"
  [3]=>
  string(242) "&#nl        The FDA is inviting comments, for consideration by WHO, concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight narcotic drugs.&#nl      "
  ["description"]=>
  string(242) "&#nl        The FDA is inviting comments, for consideration by WHO, concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight narcotic drugs.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(90) "https://www.fdanews.com/articles/214021-fda-seeks-comments-on-eight-drugs-on-behalf-of-who"
  ["blog_url"]=>
  string(90) "https://www.fdanews.com/articles/214021-fda-seeks-comments-on-eight-drugs-on-behalf-of-who"
  [15]=>
  string(19) "2024-08-15 23:23:36"
  ["add_date"]=>
  string(19) "2024-08-15 23:23:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9338"
  ["article_id"]=>
  string(4) "9338"
  [1]=>
  string(84) "BIO Raps “Questionable Data” in New Studies on IRA Impact on Biotech R&D"
  ["article_title"]=>
  string(84) "BIO Raps “Questionable Data” in New Studies on IRA Impact on Biotech R&D"
  [2]=>
  string(153) "&#nl        Ensuring that laws such as the Inflation Reduction Act (IRA) do not have unexpected consequences or diminish patient-centric innovation requi"
  ["short_description"]=>
  string(153) "&#nl        Ensuring that laws such as the Inflation Reduction Act (IRA) do not have unexpected consequences or diminish patient-centric innovation requi"
  [3]=>
  string(353) "&#nl        Ensuring that laws such as the Inflation Reduction Act (IRA) do not have unexpected consequences or diminish patient-centric innovation requires a clear-eyed view of the way that legislation operates in the real world, the Biotechnology Innovation Organization (BIO) said in response to two studies conducted by Bentley University.&#nl      "
  ["description"]=>
  string(353) "&#nl        Ensuring that laws such as the Inflation Reduction Act (IRA) do not have unexpected consequences or diminish patient-centric innovation requires a clear-eyed view of the way that legislation operates in the real world, the Biotechnology Innovation Organization (BIO) said in response to two studies conducted by Bentley University.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(114) "https://www.fdanews.com/articles/214019-bio-raps-questionable-data-in-new-studies-on-ira-impact-on-biotech-r-and-d"
  ["blog_url"]=>
  string(114) "https://www.fdanews.com/articles/214019-bio-raps-questionable-data-in-new-studies-on-ira-impact-on-biotech-r-and-d"
  [15]=>
  string(19) "2024-08-15 23:20:12"
  ["add_date"]=>
  string(19) "2024-08-15 23:20:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:19:04"
  ["create_at"]=>
  string(19) "2024-08-24 15:19:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9395"
  ["article_id"]=>
  string(4) "9395"
  [1]=>
  string(34) "The use of PPSU in medical devices"
  ["article_title"]=>
  string(34) "The use of PPSU in medical devices"
  [2]=>
  string(150) "Yahtanhoya Moreno, MarCom specialist, consumer goods & healthcare, Syensqo, discusses revolutionising medical devices with the use of PPSU, which "
  ["short_description"]=>
  string(150) "Yahtanhoya Moreno, MarCom specialist, consumer goods & healthcare, Syensqo, discusses revolutionising medical devices with the use of PPSU, which "
  [3]=>
  string(190) "Yahtanhoya Moreno, MarCom specialist, consumer goods & healthcare, Syensqo, discusses revolutionising medical devices with the use of PPSU, which combines performance with visual appeal."
  ["description"]=>
  string(190) "Yahtanhoya Moreno, MarCom specialist, consumer goods & healthcare, Syensqo, discusses revolutionising medical devices with the use of PPSU, which combines performance with visual appeal."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(142) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-materials-insights/the-use-of-ppsu-in-medical-devices/"
  ["blog_url"]=>
  string(142) "https://www.medicalplasticsnews.com/medical-plastics-industry-insights/medical-plastics-materials-insights/the-use-of-ppsu-in-medical-devices/"
  [15]=>
  string(19) "2024-08-15 23:00:00"
  ["add_date"]=>
  string(19) "2024-08-15 23:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9531"
  ["article_id"]=>
  string(4) "9531"
  [1]=>
  string(70) "Gilead gains accelerated FDA approval for rare liver disease treatment"
  ["article_title"]=>
  string(70) "Gilead gains accelerated FDA approval for rare liver disease treatment"
  [2]=>
  string(98) "Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug"
  ["short_description"]=>
  string(98) "Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug"
  [3]=>
  string(98) "Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug"
  ["description"]=>
  string(98) "Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(176) "https://www.biopharma-reporter.com/Article/2024/08/15/gilead-gains-accelerated-fda-approval-for-rare-liver-disease-treatment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(176) "https://www.biopharma-reporter.com/Article/2024/08/15/gilead-gains-accelerated-fda-approval-for-rare-liver-disease-treatment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-15 22:08:00"
  ["add_date"]=>
  string(19) "2024-08-15 22:08:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:26:38"
  ["create_at"]=>
  string(19) "2024-08-24 15:26:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9396"
  ["article_id"]=>
  string(4) "9396"
  [1]=>
  string(68) "Accumold demonstrates innovation in micromoulding at MEDevice Boston"
  ["article_title"]=>
  string(68) "Accumold demonstrates innovation in micromoulding at MEDevice Boston"
  [2]=>
  string(142) "At the MEDevice show in Boston on 25-26th September, Accumold will showcase a variety of innovative medical parts and components at booth 815."
  ["short_description"]=>
  string(142) "At the MEDevice show in Boston on 25-26th September, Accumold will showcase a variety of innovative medical parts and components at booth 815."
  [3]=>
  string(142) "At the MEDevice show in Boston on 25-26th September, Accumold will showcase a variety of innovative medical parts and components at booth 815."
  ["description"]=>
  string(142) "At the MEDevice show in Boston on 25-26th September, Accumold will showcase a variety of innovative medical parts and components at booth 815."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(132) "https://www.medicalplasticsnews.com/news/medical-plastics-company-news/accumold-demonstrates-innovation-in-micromoulding-at-medevic/"
  ["blog_url"]=>
  string(132) "https://www.medicalplasticsnews.com/news/medical-plastics-company-news/accumold-demonstrates-innovation-in-micromoulding-at-medevic/"
  [15]=>
  string(19) "2024-08-15 19:30:00"
  ["add_date"]=>
  string(19) "2024-08-15 19:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9385"
  ["article_id"]=>
  string(4) "9385"
  [1]=>
  string(95) "Got groundbreaking microbiome-related research to shout about? Probiota wants to hear from you!"
  ["article_title"]=>
  string(95) "Got groundbreaking microbiome-related research to shout about? Probiota wants to hear from you!"
  [2]=>
  string(150) "Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic and microbiome science relevant to human heal"
  ["short_description"]=>
  string(150) "Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic and microbiome science relevant to human heal"
  [3]=>
  string(228) "Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!"
  ["description"]=>
  string(228) "Are you researching the latest state-of-the-art developments related to prebiotic, probiotic, postbiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(172) "https://www.nutraingredients.com/Article/2024/08/15/Probiota-calls-for-entries-for-its-2025-Scientific-Frontiers-Session?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(172) "https://www.nutraingredients.com/Article/2024/08/15/Probiota-calls-for-entries-for-its-2025-Scientific-Frontiers-Session?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-15 18:09:00"
  ["add_date"]=>
  string(19) "2024-08-15 18:09:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:29"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9397"
  ["article_id"]=>
  string(4) "9397"
  [1]=>
  string(52) "SABIC to highlight dielectric film at PCIM Asia 2024"
  ["article_title"]=>
  string(52) "SABIC to highlight dielectric film at PCIM Asia 2024"
  [2]=>
  string(144) "SABIC will highlight the first commercial application of its high-heat ELCRES HTV150A dielectric film at PCIM Asia 2024 (in Hall 11, Booth H03)."
  ["short_description"]=>
  string(144) "SABIC will highlight the first commercial application of its high-heat ELCRES HTV150A dielectric film at PCIM Asia 2024 (in Hall 11, Booth H03)."
  [3]=>
  string(144) "SABIC will highlight the first commercial application of its high-heat ELCRES HTV150A dielectric film at PCIM Asia 2024 (in Hall 11, Booth H03)."
  ["description"]=>
  string(144) "SABIC will highlight the first commercial application of its high-heat ELCRES HTV150A dielectric film at PCIM Asia 2024 (in Hall 11, Booth H03)."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(89) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/sabic-to-highlight/"
  ["blog_url"]=>
  string(89) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/sabic-to-highlight/"
  [15]=>
  string(19) "2024-08-15 17:48:23"
  ["add_date"]=>
  string(19) "2024-08-15 17:48:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}